Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $4,331,581.01 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 278,917 shares of the business's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $15.53, for a total transaction of $4,331,581.01. Following the completion of the transaction, the president now directly owns 2,303,975 shares of the company's stock, valued at $35,780,731.75. The trade was a 10.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC traded up $0.13 on Monday, reaching $15.02. 2,232,665 shares of the company were exchanged, compared to its average volume of 2,080,941. The company has a 50-day moving average of $13.97 and a 200-day moving average of $12.23. The firm has a market cap of $2.88 billion, a price-to-earnings ratio of -19.51 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $16.25.

Remove Ads

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of ALHC. Verition Fund Management LLC boosted its holdings in shares of Alignment Healthcare by 85.3% during the third quarter. Verition Fund Management LLC now owns 121,180 shares of the company's stock valued at $1,432,000 after acquiring an additional 55,771 shares during the period. JPMorgan Chase & Co. grew its position in Alignment Healthcare by 249.3% in the third quarter. JPMorgan Chase & Co. now owns 288,219 shares of the company's stock worth $3,407,000 after buying an additional 205,705 shares during the last quarter. Principal Financial Group Inc. raised its holdings in Alignment Healthcare by 1,335.1% during the 3rd quarter. Principal Financial Group Inc. now owns 194,043 shares of the company's stock worth $2,294,000 after buying an additional 180,522 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in shares of Alignment Healthcare by 132.2% in the third quarter. The Manufacturers Life Insurance Company now owns 128,933 shares of the company's stock valued at $1,524,000 after purchasing an additional 73,402 shares in the last quarter. Finally, Barclays PLC lifted its position in shares of Alignment Healthcare by 144.1% in the third quarter. Barclays PLC now owns 193,446 shares of the company's stock worth $2,287,000 after purchasing an additional 114,191 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently commented on ALHC shares. JPMorgan Chase & Co. increased their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a "neutral" rating in a research note on Thursday. Bank of America boosted their target price on Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. Stephens reaffirmed an "overweight" rating and set a $17.00 price objective on shares of Alignment Healthcare in a report on Monday, February 24th. William Blair reissued an "outperform" rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Finally, Piper Sandler boosted their price target on Alignment Healthcare from $14.00 to $21.00 and gave the stock an "overweight" rating in a research note on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Alignment Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.